Moderna, Merck cancer vaccine scores big win in late-stage melanoma trial

Moderna and Merck's personalised mRNA vaccine met key goals in a Phase 3 melanoma trial, reducing recurrence and spread and raising hopes for a new generation of cancer vaccines worldwide

Read full article at Business Standard →

Moderna-Merck cancer vaccine trial succeeds

Moderna and Merck breakthrough could usher in wave of cancer vaccines TimesLIVE — Aug 20, 06:25 AM
What is Moderna’s new cancer vaccine and how big a breakthrough is it? Irish Times — Aug 20, 05:33 AM
Moderna-Merck may spark cancer vaccine wave The Economic Times — Aug 20, 05:30 AM
Moderna, Merck breakthrough could usher in wave of cancer vaccines Rappler — Aug 20, 02:53 AM
Skin cancer breakthrough delivers second act for Moderna's mRNA vaccines The National (UAE) — Aug 20, 03:51 AM